Valuation
- Market cap
- 2,043,770,000
- Revenue TTM
- $427,540,000
- Net income TTM
- $-21,020,000
- PE ratio
- 198.67
- Forward PE
- —
- Profit margin
- -4.92%
- Debt to equity
- 0.40
Trading
- Volume
- 734,700
- Avg volume
- 747,228
- Day's range
- $64.50 – $67.94
- Shares out
- 29,823,000
- Stochastic %K
- 13%
- Beta
- 1.95
- Analysts
- Strong Sell
- Price target
- $91.44
Company profile
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx H...
Show more
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- Phone
- 888 729 1206
- Website
- https://www.genedx.com
- Address
- North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
Latest news
No headlines yet.
